MSOPCAS# 66515-29-5 |
2D Structure
- RVX-208
Catalog No.:BCC4475
CAS No.:1044870-39-4
- GSK 525768A
Catalog No.:BCC1603
CAS No.:1260530-25-3
- Bromodomain Inhibitor, (+)-JQ1
Catalog No.:BCC1132
CAS No.:1268524-70-4
- I-BET151 (GSK1210151A)
Catalog No.:BCC4476
CAS No.:1300031-49-5
- CPI-203
Catalog No.:BCC4099
CAS No.:1446144-04-2
- OTX-015
Catalog No.:BCC1829
CAS No.:202590-98-5
Quality Control & MSDS
3D structure
Package In Stock
Number of papers citing our products
Cas No. | 66515-29-5 | SDF | Download SDF |
PubChem ID | 3964633 | Appearance | Powder |
Formula | C4H10NO6P | M.Wt | 199.1 |
Type of Compound | N/A | Storage | Desiccate at -20°C |
Solubility | Soluble to 100 mM in sterile water | ||
Chemical Name | 2-amino-2-methyl-3-phosphonooxypropanoic acid | ||
SMILES | CC(COP(=O)(O)O)(C(=O)O)N | ||
Standard InChIKey | GSFCOAGADOGIGE-UHFFFAOYSA-N | ||
Standard InChI | InChI=1S/C4H10NO6P/c1-4(5,3(6)7)2-11-12(8,9)10/h2,5H2,1H3,(H,6,7)(H2,8,9,10) | ||
General tips | For obtaining a higher solubility , please warm the tube at 37 ℃ and shake it in the ultrasonic bath for a while.Stock solution can be stored below -20℃ for several months. We recommend that you prepare and use the solution on the same day. However, if the test schedule requires, the stock solutions can be prepared in advance, and the stock solution must be sealed and stored below -20℃. In general, the stock solution can be kept for several months. Before use, we recommend that you leave the vial at room temperature for at least an hour before opening it. |
||
About Packaging | 1. The packaging of the product may be reversed during transportation, cause the high purity compounds to adhere to the neck or cap of the vial.Take the vail out of its packaging and shake gently until the compounds fall to the bottom of the vial. 2. For liquid products, please centrifuge at 500xg to gather the liquid to the bottom of the vial. 3. Try to avoid loss or contamination during the experiment. |
||
Shipping Condition | Packaging according to customer requirements(5mg, 10mg, 20mg and more). Ship via FedEx, DHL, UPS, EMS or other couriers with RT, or blue ice upon request. |
Description | Selective group III metabotropic glutamate receptor antagonist. Displays an apparent KD of 51 μM for the L-AP4-sensitive presynaptic mGluR on primary afferent terminals in spinal cord compared to > 700 μM for the (1S,3S)-ACPD-sensitive presynaptic mGlu in the same system. Has no activity on postsynaptic mGlu receptors or on ionotropic glutamate receptors on neonatal rat motoneurons. Also available as part of the Group III mGlu Receptor Tocriset™. |
MSOP Dilution Calculator
MSOP Molarity Calculator
1 mg | 5 mg | 10 mg | 20 mg | 25 mg | |
1 mM | 5.0226 mL | 25.113 mL | 50.226 mL | 100.452 mL | 125.565 mL |
5 mM | 1.0045 mL | 5.0226 mL | 10.0452 mL | 20.0904 mL | 25.113 mL |
10 mM | 0.5023 mL | 2.5113 mL | 5.0226 mL | 10.0452 mL | 12.5565 mL |
50 mM | 0.1005 mL | 0.5023 mL | 1.0045 mL | 2.009 mL | 2.5113 mL |
100 mM | 0.0502 mL | 0.2511 mL | 0.5023 mL | 1.0045 mL | 1.2557 mL |
* Note: If you are in the process of experiment, it's necessary to make the dilution ratios of the samples. The dilution data above is only for reference. Normally, it's can get a better solubility within lower of Concentrations. |
Calcutta University
University of Minnesota
University of Maryland School of Medicine
University of Illinois at Chicago
The Ohio State University
University of Zurich
Harvard University
Colorado State University
Auburn University
Yale University
Worcester Polytechnic Institute
Washington State University
Stanford University
University of Leipzig
Universidade da Beira Interior
The Institute of Cancer Research
Heidelberg University
University of Amsterdam
University of Auckland
TsingHua University
The University of Michigan
Miami University
DRURY University
Jilin University
Fudan University
Wuhan University
Sun Yat-sen University
Universite de Paris
Deemed University
Auckland University
The University of Tokyo
Korea University
- Bicifadine hydrochloride
Catalog No.:BCC7925
CAS No.:66504-75-4
- Amantadine HCl
Catalog No.:BCC4465
CAS No.:665-66-7
- JW 55
Catalog No.:BCC2453
CAS No.:664993-53-7
- H-D-Lys(Boc)-OMe.HCl
Catalog No.:BCC2990
CAS No.:66494-53-9
- Kaempferol 3-O-(6''-O-acetyl)glucoside-7-O-rhamnoside
Catalog No.:BCN1385
CAS No.:66465-24-5
- 2-(2,4-Diaminophenoxy)ethanol dihydrochloride
Catalog No.:BCN8497
CAS No.:66422-95-5
- 6-Amino-1,3-dimethyluracil
Catalog No.:BCC8755
CAS No.:6642-31-5
- 13-Hydroxyoxyberberine
Catalog No.:BCN3355
CAS No.:66408-27-3
- Pamoic acid disodium salt
Catalog No.:BCC7909
CAS No.:6640-22-8
- 5alpha-Hydroxychloranthalactone A
Catalog No.:BCN7469
CAS No.:66395-04-8
- Chloranthalactone B
Catalog No.:BCN8020
CAS No.:66395-03-7
- Chloranthalactone A
Catalog No.:BCN8022
CAS No.:66395-02-6
- Benzoin isopropyl ether
Catalog No.:BCC8856
CAS No.:6652-28-4
- Propacetamol hydrochloride
Catalog No.:BCC9129
CAS No.:66532-86-3
- Ansamitocin P-3
Catalog No.:BCN8373
CAS No.:66547-09-9
- Augustifolin
Catalog No.:BCN3232
CAS No.:66548-01-4
- CL 218872
Catalog No.:BCC7162
CAS No.:66548-69-4
- ent-3beta-Hydroxykaur-16-en-19-oic acid
Catalog No.:BCN6472
CAS No.:66556-91-0
- Tsugafolin
Catalog No.:BCN4026
CAS No.:66568-97-6
- Forskolin
Catalog No.:BCN2332
CAS No.:66575-29-9
- Dihydrorotenone
Catalog No.:BCN2726
CAS No.:6659-45-6
- Agaric acid
Catalog No.:BCC9216
CAS No.:666-99-9
- Boc-Phenylalaninol
Catalog No.:BCC2718
CAS No.:66605-57-0
- RU 24969
Catalog No.:BCC5423
CAS No.:66611-26-5
Educating medical students as competent users of health information technologies: the MSOP data.[Pubmed:17911947]
Stud Health Technol Inform. 2007;129(Pt 2):1414-8.
UNLABELLED: As more health information technologies become part of the health care environment, the need for physicians with medical informatics competencies is growing. In 2006, a survey was created to determine the degree to which the Association of American Medical College's Medical School Objectives Project (MSOP) medical informatics competencies had been incorporated into medical school curricula in the United States. METHODS: a web-based tool was used to create the survey; medical education deans or their designees were requested to complete the survey. Analysis focused on the clinician, researcher, and manager roles of physicians. RESULTS: Seventy usable surveys were returned. Many of the objectives were stated in the schools' respective curricula and the competencies were being evaluated. However, only a few schools taught and assessed the medical informatics objectives that required interaction with health information. CONCLUSION: To insure that physicians have the knowledge, skills, and attitudes to effectively and efficiently interact with today's health information technologies, more medical informatics concepts need to be included and assessed in all undergraduate medical education curricula in the United States.